Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae

Phage lysins constitute a new generation of antimicrobials that are becoming a promising alternative and complementation to current antibiotic therapies, which are nowadays called into question by the increasing numbers of multiresistant bacteria. Streptococcus pneumoniae is a leading human pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez, Roberto, García, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560164/
https://www.ncbi.nlm.nih.gov/pubmed/31231338
http://dx.doi.org/10.3389/fmicb.2019.01251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560164/
https://www.ncbi.nlm.nih.gov/pubmed/31231338
http://dx.doi.org/10.3389/fmicb.2019.01251

Ejemplares similares